Australia and New Zealand Biotech & Life Sciences Reservations open Page created Nov 16, 2026

List of FSANZ Applications for Precision Fermentation Ingredients

Applications lodged with Food Standards Australia New Zealand (FSANZ) for ingredients made by microbial or precision fermentation: animal-free dairy proteins, sweet proteins, human-milk oligosaccharides and enzyme processing aids from GM production strains, with the applicant, production organism, procedure level and assessment status of each.

Fields we plan to include

Applicant
Application number
Ingredient
Production organism
Gene donor
Category (novel food, processing aid, nutritive substance, additive)
Date received
Procedure and level
Assessment stage
FSANZ Board approval date
Affected standards and schedules
Applicant country

Data Preview

* Free sample rows, unverified and may contain errors. This list isn't for sale yet.
ApplicantApplicationIngredientDate received
Eden Brew Pty LtdSourceA1342Beta-casein protein preparation (BCPP1) from GM Komagataella phaffii15 October 2025
MycoTechnology Inc.SourceA1359Honey truffle sweet protein from Komagataella phaffii15 June 2026
Advanced Protein Technologies Corp.SourceA12832′-FL from GM Corynebacterium glutamicum4 September 2023
Synaura Biotechnology (Shanghai) Co., Ltd.SourceA13362′-FL from GM Escherichia coli BL2119 June 2025
Cataya Bio (Shanghai) Company LimitedSourceA13342′-FL from GM Corynebacterium glutamicum3 June 2025

Estimated ~150 entries. If people reserve it, we'll try to compile it (we can't compile every list).

* No charge now. Purchase is optional.

How fermentation-derived ingredients reach the Australia and New Zealand market

Food Standards Australia New Zealand (FSANZ) does not run a notification system for new ingredients. A company that wants to sell a protein, sweetener, oligosaccharide or enzyme made by a genetically modified microorganism generally has to lodge an application to amend the Australia New Zealand Food Standards Code. Each application receives an A-number (for example A1342) and a public page on the FSANZ website, and its progress is documented in a series of reports. For anyone tracking precision fermentation in the region, those A-numbers are the most reliable trail of who is trying to enter the market, with which production strain, and how far they have got.

What counts as a fermentation-derived application

FSANZ files applications by regulatory category rather than by production technology, so fermentation-derived ingredients appear across several categories:

  • Processing aids – enzymes such as cellulase, lipase, glucoamylase, transglutaminase or thermolysin produced by strains of Trichoderma reesei, Aspergillus niger, Bacillus species and others. This is the largest group; FSANZ's own application register files more than a hundred applications under the processing-aid category.
  • Nutritive substances for infant formula – human-milk oligosaccharides (2′-FL, 3-FL, LNT, 3′-SL, 6′-SL) made by GM Escherichia coli or Corynebacterium glutamicum. Several applications cover a new production strain for a substance that is already permitted.
  • Novel foods and GM ingredients – animal-free dairy proteins and other proteins expressed in yeasts such as Komagataella phaffii, as well as fungal biomass ingredients.
  • Food additives – for example sweet proteins expressed in yeast and proposed as intense sweeteners, and steviol glycosides produced by fermentation or enzymatic conversion.

Reading an application file

The most information-dense document in each file is the Administrative Assessment Report, published when FSANZ accepts the application. It states the date received, the applicant, a brief description, the procedure and its level, the maximum variable hours FSANZ expects to spend, and the standards or schedules likely to be affected. The procedure level is a useful proxy for regulatory complexity:

ExampleProcedureMax. variable hours
A1334 – new 2′-FL production strainGeneral Level 2290
A1359 – sweet protein as a food additiveGeneral Level 3420
A1339 – five HMOs from GM E. coli BL21General Level 5658
A1342 – beta-casein protein preparation from GM yeastGeneral Level 5668

After acceptance, a file typically moves through a call for submissions (with a risk and technical assessment published as a supporting document), an approval report and a decision by the FSANZ Board, followed by consideration by food ministers before the change is gazetted. For example, the Board approved A1334 on 10 March 2026, and A1339 and A1340 on 3 June 2026.

Why the production organism matters

Approval is tied to a specific source organism and, for GM strains, often to the gene donor as well. A competitor making the same molecule with a different strain usually needs its own application, which is why the register contains a run of 2′-FL applications from different producers and strains. The production organism and gene donor are therefore the fields that tell a regulatory team whether an existing permission can be relied on or whether a new dossier is needed.

Who uses this information

  • Regulatory consultants benchmarking timelines and procedure levels before quoting a new dossier.
  • Precision fermentation start-ups and investors checking which competitors have filed in Australia and New Zealand, and at what stage.
  • Ingredient distributors and food manufacturers identifying suppliers whose ingredients are permitted or approaching approval in the region.

Frequently Asked Questions

Q.Does a new production strain need its own FSANZ application if the ingredient is already permitted?

Often yes. Permissions for ingredients from GM microorganisms are tied to the source organism, so FSANZ has assessed multiple applications for the same molecule, such as 2′-FL, each covering a new genetically modified production strain.

Q.What is an FSANZ Administrative Assessment Report?

It is the document FSANZ publishes when it accepts an application. It records the date received, the applicant, a brief description, the procedure and level, the maximum variable hours and the standards or schedules likely to be affected.

Q.What do the FSANZ procedure levels indicate?

The level reflects the expected complexity of the assessment and is linked to the maximum number of variable hours FSANZ budgets. A new strain for an already-permitted HMO may be assessed at a lower level, while a new protein for use across many foods can be assessed at the highest general level.

Q.Is FSANZ Board approval the final step?

No. After the FSANZ Board approves a variation to the Food Standards Code, food ministers are notified and may request a review; the change takes effect once it is gazetted.

Q.Can I buy the list now?

Not yet. Sample rows are free. We try to compile lists that people reserve (we can't compile every list). If we do, we'll email everyone who reserved it a purchase link (buying is optional). If we don't, nothing happens and you're never charged.

Q.What does it cost?

Sample rows are free. A list is $49, paid only if we compile it and you decide to buy. There is no free trial or subscription.